University of California, Davis Comprehensive Cancer Center — Sacramento, California

University of California, Davis Comprehensive Cancer Center is a clinical research site located in Sacramento, California, United States 95817.

Crixeo Health Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.

University of California, Davis Comprehensive Cancer Center has participated in 25 clinical trials with 15 currently active.

Therapeutic areas: Endometrial Adenocarcinoma, Myelodysplastic Syndromes, Head and Neck Squamous Cell Carcinoma.

Sponsors: Acrivon Therapeutics, Gilead Sciences, Bicara Therapeutics.

Sponsor Feasibility Report

Trust Score: 83/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of California, Davis Comprehensive Cancer Center?

University of California, Davis Comprehensive Cancer Center has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of California, Davis Comprehensive Cancer Center conducted?

University of California, Davis Comprehensive Cancer Center has 25 clinical trials on record, with 15 currently active. Their work covers Endometrial Adenocarcinoma, Myelodysplastic Syndromes, Head and Neck Squamous Cell Carcinoma.

Is University of California, Davis Comprehensive Cancer Center accredited by Crixeo Health?

Yes — University of California, Davis Comprehensive Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about University of California, Davis Comprehensive Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.